Amid criticisms this week that his former university didn’t do all it should have to investigate his work, another paper by Dirk Smeesters has been retracted.
Here’s the notice for “The effect of color (red versus blue) on assimilation versus contrast in prime-to-behavior effects,” which appeared in The Journal of Experimental Social Psychology: Continue reading Retraction three for Dirk Smeesters
In August of last year, Mladen Pavičić, chair of physics at the University of Zagreb’s Faculty of Civil Engineering, published a paper in Physical Review Letters on quantum teleportation, “Near-Deterministic Discrimination of All Bell States with Linear Optics.”
Just six days later, after hearing from a physicist in China, Pavičić — who is also affiliated with Harvard’s physics department — submitted a correction, which ran on the journal’s site in November. The correction begins: Continue reading Poignancy in physics: Retraction for “fatal error” that couldn’t be patched
We’re a few months late on this one, but Heart, a BMJ title, issued a fascinating retraction notice in August about a meta-analysis on percutaneous coronary intervention (that’s stenting to you and me) after suffering a heart attack, and the drug abciximab, which is used to prevent clotting and additional near-term heart attacks. Abciximab is sold as ReoPro by Eli Lilly.
The article, “Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient-data pooled analysis of randomised studies,” was published last May. But according to the retraction notice, the authors had neglected to include fresh data, already in the literature before their paper went live, that contradicted their overall findings.
Here’s the notice: Continue reading Heart retracts stent-ReoPro paper over data dispute with authors (save one)
Dipak Das, the resveratrol researcher found guilty of more than 100 counts of misconduct by the University of Connecticut, has two more retractions for his resume. But that’s not the most interesting part of this post, so keep reading after the notices.
Both retractions appeared in the October 2012 issue of the Journal of Cellular and Molecular Medicine. Here’s the first notice: Continue reading Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss
The Howard Hughes Medical Institute (HHMI) asked a journal to retract a paper once it became clear that some of the images in it were actually from a different HHMI lab.
Here’s the notice, from the Journal of Comparative Neurology: Continue reading Neuroscience paper retracted after HHMI investigation finds scientist copied images without permission
Biological Trace Element Research has retracted a paper by a group of Egyptian authors for duplication.
The paper, “The Effect of Lead Acetate Toxicity on Experimental Male Albino Rat,” came from investigators in the department of Economic Entomology and Pesticides at Cairo University and appeared in December 2011. As the notice states:
Article has been retracted due to duplicate publication.
Here’s the abstract: Continue reading Get the lead out: duplication leads to retraction of heavy metal paper
This one is an oldie but a goodie.
We’ve published a few accounts of what it feels like to have your work plagiarized. But often absent from accounts like that are the views of the plagiarists. So here’s one.
In 2009, the Cuban Journal of Endocrinology retracted a 2000 paper by a researcher who acknowledged plagiarizing the work from a previously-published book chapter by other authors. And how.
As a letter from the editors explains (with the help of Google Translate): Continue reading I will not plagiarize, I will not plagiarize, No plagiaré…: When a journal requires a public apology
Jesús A. Lemus, the Spanish researcher whose work has left a lot of people questioning his data, has another Expression of Concern for his resume.
Here’s the notice, from Functional Ecology: Continue reading Not immune: Jesús A. Lemus earns another Expression of Concern
The Journal of Vascular Surgery is retracting — with vigor — a paper it published online in March after discovering that the authors had published essentially the same article for the Journal of the European Academy of Dermatology and Venereology some months earlier.
Both papers are titled “Randomized controlled trial comparing treatment outcome of two compression bandaging systems and standard care without compression in patients with venous leg ulcers.” The work was funded by the Health, Welfare and Food Bureau of Hong Kong and a grant from Lohmann & Rauscher GmbH & Co KG, a German company that makes compression bandages and other surgical supplies.
According to the retraction notice in JVS: Continue reading Double bind: Duplication of bandaging paper leads to retraction
Has the Annals of Thoracic Surgery had a change of heart? Evidently the publication that told us nearly two years ago, in effect, that the reasons for retractions in its pages were “none of [our] damn business” has decided that information is worth sharing after all.
The ATS has retracted a paper it published in October. The article, titled “Development and Validation of a New Outcome Score in Subglottic Stenosis,” came from a group of researchers in Florence, Italy.
As the notice explains: Continue reading “Misconduct” leads to retraction from Italian “super surgeon” under house arrest